{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T17:12:10Z","timestamp":1779210730220,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Primary amoebic meningoencephalitis (PAM) caused by\n                      <jats:italic>Naegleria fowleri<\/jats:italic>\n                      carries historical case fatality rates (CFR) exceeding 97%. The 2025 Kerala outbreak, the largest documented globally, provided an unprecedented opportunity to identify host factors and inflammatory correlates influencing survival under standardised management.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective observational study of 200 laboratory-confirmed PAM cases across six districts of Kerala, India (January\u2013November 2025). All patients received protocolised amphotericin B \u00b1 miltefosine. Demographic, clinical, and laboratory data were collected, including inflammatory biomarkers (IL-6, TNF-\u03b1, IL-1\u03b2, neutrophil-to-lymphocyte ratio), pathogen burden (qPCR), and treatment timing. Multivariable logistic regression identified mortality predictors; bootstrap resampling and E-value sensitivity analyses assessed robustness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Here we show that among 200 patients (median age 41 years; 50% male), 134 with resolved outcomes yield a CFR of 45\u00b75% (95% CI 37\u00b73\u201354\u00b75%; 61 deaths, 73 recoveries). Diabetes mellitus is the only statistically significant predictor of mortality in the adjusted model (adjusted OR 2\u00b759; 95% CI 1\u00b701\u20136\u00b766;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090\u00b7048), though the proximity of the lower confidence bound to unity warrants cautious interpretation. This association remains consistent across sensitivity analyses (bootstrap 95% CI 1\u00b706\u20138\u00b774; E-value 4\u00b762). Asthma demonstrates a protective association in univariable analysis (OR 0\u00b737;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090\u00b7021), though this finding remains hypothesis-generating. Early treatment (\u22642 days) shows a trend toward improved survival (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090\u00b7084). Inflammatory biomarkers show no association with outcome, though CSF pathogen burden correlates significantly with admission neurological severity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Under standardised treatment, diabetes mellitus emerges as a key host determinant of PAM mortality. The dissociation between inflammatory markers and outcomes suggests neurological fate may be determined early in infection, with immediate clinical implications as climate change expands the geographic range of\n                      <jats:italic>N. fowleri<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-026-01658-8","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:07:10Z","timestamp":1779206830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Host factors, inflammatory markers, and clinical outcomes of Naegleria fowleri meningoencephalitis"],"prefix":"10.1038","volume":"6","author":[{"given":"Vijeesh","family":"Kadukkatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brijil K.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Mac","family":"Asaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"1658_CR1","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1093\/cid\/ciaa520","volume":"73","author":"R Gharpure","year":"2021","unstructured":"Gharpure, R. et al. Epidemiology and clinical characteristics of primary amebic meningoencephalitis caused by Naegleria fowleri: a global review. Clin. Infect. Dis. 73, e19\u2013e27 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"1658_CR2","doi-asserted-by":"publisher","first-page":"e3017","DOI":"10.1371\/journal.pntd.0003017","volume":"8","author":"R Siddiqui","year":"2014","unstructured":"Siddiqui, R. & Khan, N. A. Primary amoebic meningoencephalitis caused by Naegleria fowleri: an old enemy presenting new challenges. PLoS Negl. Trop. Dis. 8, e3017 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1658_CR3","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.1128\/AAC.01293-15","volume":"59","author":"E Grace","year":"2015","unstructured":"Grace, E., Asbill, S. & Virga, K. Naegleria fowleri: pathogenesis, diagnosis, and treatment options. Antimicrob. Agents Chemother. 59, 6677\u20136681 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"1658_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pt.2019.10.008","volume":"36","author":"SK Maciver","year":"2020","unstructured":"Maciver, S. K., Pi\u00f1ero, J. E. & Lorenzo-Morales, J. Is Naegleria fowleri an emerging parasite? Trends Parasitol. 36, 19\u201328 (2020).","journal-title":"Trends Parasitol."},{"key":"1658_CR5","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1542\/peds.2014-2292","volume":"135","author":"WM Linam","year":"2015","unstructured":"Linam, W. M. et al. Successful treatment of an adolescent with Naegleria fowleri primary amebic meningoencephalitis. Pediatrics 135, e744\u2013e748 (2015).","journal-title":"Pediatrics"},{"key":"1658_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.tmaid.2017.11.010","volume":"20","author":"TW Heggie","year":"2017","unstructured":"Heggie, T. W. & K\u00fcpper, T. Surviving Naegleria fowleri infections: a systematic review of the literature. Travel Med. Infect. Dis. 20, 83\u201387 (2017).","journal-title":"Travel Med. Infect. Dis."},{"key":"1658_CR7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s11684-021-0865-2","volume":"15","author":"H Zhang","year":"2021","unstructured":"Zhang, H. & Cheng, X. Various brain-eating amoebae: the protozoa, the pathogenesis, and the disease. Front. Med. 15, 842\u2013866 (2021).","journal-title":"Front. Med."},{"key":"1658_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3201\/eid2701.202119","volume":"27","author":"R Gharpure","year":"2021","unstructured":"Gharpure, R. et al. Geographic range of recreational water-associated primary amebic meningoencephalitis, United States, 1978\u20132018. Emerg. Infect. Dis. 27, 271\u2013274 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"1658_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/cid\/cir961","volume":"54","author":"SK Kemble","year":"2012","unstructured":"Kemble, S. K. et al. Fatal Naegleria fowleri infection acquired in Minnesota: possible expanded range of a deadly thermophilic organism. Clin. Infect. Dis. 54, 805\u2013809 (2012).","journal-title":"Clin. Infect. Dis."},{"key":"1658_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2019.e00524","volume":"15","author":"SG Gompf","year":"2019","unstructured":"Gompf, S. G. & Garcia, C. Lethal encounters: the evolving spectrum of amoebic meningoencephalitis. IDCases 15, e00524 (2019).","journal-title":"IDCases"},{"key":"1658_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3201\/eid1702.100442","volume":"17","author":"S Shakoor","year":"2011","unstructured":"Shakoor, S. et al. Primary amebic meningoencephalitis caused by Naegleria fowleri, Karachi, Pakistan. Emerg. Infect. Dis. 17, 258\u2013261 (2011).","journal-title":"Emerg. Infect. Dis."},{"key":"1658_CR12","unstructured":"Kerala State Health Department. Naegleria fowleri Outbreak Investigation Report (Directorate of Health Services, 2025)."},{"key":"1658_CR13","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3390\/biom11091320","volume":"11","author":"A G\u00fc\u00e9mez","year":"2021","unstructured":"G\u00fc\u00e9mez, A. & Garc\u00eda, E. Primary amoebic meningoencephalitis by Naegleria fowleri: pathogenesis and treatments. Biomolecules 11, 1320 (2021).","journal-title":"Biomolecules"},{"key":"1658_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1574-695X.2007.00332.x","volume":"51","author":"F Marciano-Cabral","year":"2007","unstructured":"Marciano-Cabral, F. & Cabral, G. A. The immune response to Naegleria fowleri amebae and pathogenesis of infection. FEMS Immunol. Med. Microbiol. 51, 243\u2013259 (2007).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"1658_CR15","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1021\/acschemneuro.6b00232","volume":"7","author":"JJ Pugh","year":"2016","unstructured":"Pugh, J. J. & Levy, R. A. Naegleria fowleri: diagnosis, pathophysiology of brain inflammation, and antimicrobial treatments. ACS Chem. Neurosci. 7, 1178\u20131185 (2016).","journal-title":"ACS Chem. Neurosci."},{"key":"1658_CR16","first-page":"474","volume":"122","author":"R Zahorec","year":"2021","unstructured":"Zahorec, R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl. Lek. Listy 122, 474\u2013488 (2021).","journal-title":"Bratisl. Lek. Listy"},{"key":"1658_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3201\/eid2401.170545","volume":"24","author":"A Matanock","year":"2018","unstructured":"Matanock, A., Mehal, J. M., Liu, L., Blau, D. M. & Cope, J. R. Estimation of undiagnosed Naegleria fowleri primary amebic meningoencephalitis, United States. Emerg. Infect. Dis. 24, 162\u2013164 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"1658_CR18","unstructured":"Centers for Disease Control and Prevention. Treatment of Naegleria fowleri Infection (CDC; 2023)."},{"key":"1658_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-695X.2007.00232.x","volume":"50","author":"GS Visvesvara","year":"2007","unstructured":"Visvesvara, G. S., Moura, H. & Schuster, F. L. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol. Med. Microbiol. 50, 1\u201326 (2007).","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"1658_CR20","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1128\/JCM.00875-06","volume":"44","author":"Y Qvarnstrom","year":"2006","unstructured":"Qvarnstrom, Y., Visvesvara, G. S., Sriram, R. & da Silva, A. J. Multiplex real-time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri. J Clin. Microbiol. 44, 3589\u20133595 (2006).","journal-title":"J Clin. Microbiol."},{"key":"1658_CR21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele, T. J. & Ding, P. Sensitivity analysis in observational research: introducing the E-value. Ann. Intern. Med. 167, 268\u2013274 (2017).","journal-title":"Ann. Intern. Med."},{"key":"1658_CR22","unstructured":"Indian Council of Medical Research. National Ethical Guidelines for Biomedical and Health Research Involving Human Participants (ICMR, 2017)."},{"key":"1658_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1086\/431587","volume":"41","author":"LMAJ Muller","year":"2005","unstructured":"Muller, L. M. A. J. et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin. Infect. Dis. 41, 281\u2013288 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"1658_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2337\/dc17-2131","volume":"41","author":"IM Carey","year":"2018","unstructured":"Carey, I. M. et al. Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study. Diabetes Care 41, 513\u2013521 (2018).","journal-title":"Diabetes Care"},{"key":"1658_CR25","first-page":"125","volume":"2","author":"S Prasad","year":"2014","unstructured":"Prasad, S., Sajja, R. K., Naik, P. & Cucullo, L. Diabetes mellitus and blood\u2013brain barrier dysfunction: an overview. J. Pharmacovigil. 2, 125 (2014).","journal-title":"J. Pharmacovigil."},{"key":"1658_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104354","volume":"127","author":"L Roncon","year":"2020","unstructured":"Roncon, L., Zuin, M., Rigatelli, G. & Zuliani, G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. J. Clin. Virol. 127, 104354 (2020).","journal-title":"J. Clin. Virol."},{"key":"1658_CR27","first-page":"1","volume":"51","author":"C Wei\u00df","year":"2023","unstructured":"Wei\u00df, C. & Wei\u00df, G. Neutrophil-to-lymphocyte ratio as a prognostic marker in acute bacterial meningitis: a systematic review. Infection 51, 1\u201312 (2023).","journal-title":"Infection"},{"key":"1658_CR28","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ajem.2019.10.023","volume":"38","author":"Z Huang","year":"2020","unstructured":"Huang, Z., Fu, Z., Huang, W. & Huang, K. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis. Am. J. Emerg. Med. 38, 641\u2013647 (2020).","journal-title":"Am. J. Emerg. Med."},{"key":"1658_CR29","first-page":"e6","volume":"81","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J. Infect. 81, e6\u2013e12 (2020).","journal-title":"J. Infect."},{"key":"1658_CR30","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0140-6736(21)00883-7","volume":"398","author":"D van de Beek","year":"2021","unstructured":"van de Beek, D., Brouwer, M. C., Koedel, U. & Wall, E. C. Community-acquired bacterial meningitis. Lancet. 398, 1171\u20131183 (2021).","journal-title":"Lancet."},{"key":"1658_CR31","unstructured":"World Health Organization. Climate Change and Health (WHO, 2023)."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01658-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01658-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01658-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:52:11Z","timestamp":1779209531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01658-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1658"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01658-8","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}